Research Options: Select below IPO Calendar	Week of Expected Pricing pending Company Name DERMAVANT SCIENCES LTD Proposed Ticker DRMT CUSIP G2818U104 Business Description A clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology. Lead Underwriter Guggenheim Securities, LLC ,Jefferies LLC ,SVB Leerink LLC Co-Managers N/A Initial Shares 7,700,000 Revised Initial Shares N/A Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.